Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 32, 2015, Pages E4438-E4447

  Helb, Danica A ^a,b,c   Tetteh, Kevin K A ^d   Felgner, Philip L ^e   Skinner, Jeff ^f   Hubbard, Alan ^b   Arinaitwe, Emmanuel ^g   Mayanja Kizza, Harriet ^h   Ssewanyana, Isaac ^g   Kamya, Moses R ^h   Beeson, James G ⁱ   Tappero, Jordan ^j   Smith, David L ^k,l   Crompton, Peter D ^f   Rosenthal, Philip J ^a   Dorsey, Grant ^a   Drakeley, Christopher J ^d   Greenhouse, Bryan ^a   Rayner, Julian C ^m  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^g INFECTIOUS DISEASES RESEARCH COLLABORATION   (Uganda)

^h MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

ⁱ BURNET INSTITUTE   (Australia)

^j CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^k UNIVERSITY OF OXFORD   (United Kingdom)

^l SANARIA INC   (United States)

^m WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

more..

Author keywords

Antigen discovery; Epidemiology; Immunoepidemiology; Plasmodium falciparum malaria; Serology

Indexed keywords

BACTERIAL ANTIGEN; BIOLOGICAL MARKER; PARASITE ANTIGEN; PROTOZOON ANTIBODY;

ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CHILD; CROSS-SECTIONAL STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; GEOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALE; PLASMODIUM FALCIPARUM; PREDICTION; PRIORITY JOURNAL; PROTEIN MICROARRAY; RECEIVER OPERATING CHARACTERISTIC; SEROLOGY; ANTIBODY PRODUCTION; BLOOD; DEMOGRAPHY; GENE ONTOLOGY; GENETICS; IMMUNOLOGY; INCIDENCE; MALARIA, FALCIPARUM; MALI; PARASITOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; TREATMENT OUTCOME; UGANDA;

PLASMODIUM FALCIPARUM;

ANTIBODIES, PROTOZOAN; ANTIBODY FORMATION; ANTIBODY SPECIFICITY; ANTIGENS, PROTOZOAN; BIOMARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; GENE ONTOLOGY; GEOGRAPHY; HUMANS; INCIDENCE; MALARIA, FALCIPARUM; MALE; MALI; PLASMODIUM FALCIPARUM; RESIDENCE CHARACTERISTICS; ROC CURVE; TREATMENT OUTCOME; UGANDA;

EID: 84938912063     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1501705112     Document Type: Article

References (109)

1. Mendis K, et al. (2009) From malaria control to eradication: The WHO perspective. Trop Med Int Health 14(7): 802-809.
2. Woolhouse ME, et al. (1997) Heterogeneities in the transmission of infectious agents: Implications for the design of control programs. Proc Natl Acad Sci USA 94(1): 338-342.
3. Carter R, Mendis KN, Roberts D (2000) Spatial targeting of interventions against malaria. Bull World Health Organ 78(12): 1401-1411.
4. Carter R (2002) Spatial simulation of malaria transmission and its control by malaria transmission blocking vaccination. Int J Parasitol 32(13): 1617-1624.
5. Smith DL, Dushoff J, Snow RW, Hay SI (2005) The entomological inoculation rate and Plasmodium falciparum infection in African children. Nature 438(7067): 492-495.
6. Smith DL, Guerra CA, Snow RW, Hay SI (2007) Standardizing estimates of the Plasmodium falciparum parasite rate. Malar J 6: 131.
7. Cibulskis RE, et al. (2007) Estimating trends in the burden of malaria at country level. Am J Trop Med Hyg 77(6, Suppl): 133-137.
8. Hay SI, Smith DL, Snow RW (2008) Measuring malaria endemicity from intense to interrupted transmission. Lancet Infect Dis 8(6): 369-378.
9. Kelly-Hope LA, McKenzie FE (2009) The multiplicity of malaria transmission: A review of entomological inoculation rate measurements and methods across sub-Saharan Africa. Malar J 8: 19.
10. Coleman M, et al. (2009) Using the SaTScan method to detect local malaria clusters for guiding malaria control programmes. Malar J 8(1): 68.
11. Moonen B, et al. (2010) Operational strategies to achieve and maintain malaria elimination. Lancet 376(9752): 1592-1603.
12. Bousema T, et al. (2012) Hitting hotspots: Spatial targeting of malaria for control and elimination. PLoS Med 9(1): E1001165.
13. Bousema T, et al. (2013) The impact of hotspot-targeted interventions on malaria transmission: Study protocol for a cluster-randomized controlled trial. Trials 14(1): 36.
14. Sturrock HJW, et al. (2013) Reactive case detection for malaria elimination: Real-life experience from an ongoing program in Swaziland. PLoS One 8(5): E63830.
15. WHO (2013) WHO World Malaria Report 2013. Available at www.who.int/malaria/publications/world-malaria-report-2013/report/en/. Accessed September 25, 2014.
16. Akachi Y, Atun R (2011) Effect of investment in malaria control on child mortality in sub-Saharan Africa in 2002-2008. PLoS One 6(6): E21309.
17. O'Meara WP, Mangeni JN, Steketee R, Greenwood B (2010) Changes in the burden of malaria in sub-Saharan Africa. Lancet Infect Dis 10(8): 545-555.
18. Oduro AR, et al. (2013) Seroepidemiological and parasitological evaluation of the heterogeneity of malaria infection in the Gambia. Malar J 12: 222.
19. Tusting LS, Bousema T, Smith DL, Drakeley C (2014) Measuring changes in Plasmodium falciparum transmission: Precision, accuracy and costs of metrics. Advances in Parasitology, ed Rollinson D (Academic, London), pp 151-208.
20. Hay SI, Rogers DJ, Toomer JF, Snow RW (2000) Annual Plasmodium falciparum entomological inoculation rates (EIR) across Africa: Literature survey, Internet access and review. Trans R Soc Trop Med Hyg 94(2): 113-127.
21. Mbogo CM, et al. (2003) Spatial and temporal heterogeneity of Anopheles mosquitoes and Plasmodium falciparum transmission along the Kenyan coast. Am J Trop Med Hyg 68(6): 734-742.
22. Wong J, et al. (2013) Standardizing operational vector sampling techniques for measuring malaria transmission intensity: Evaluation of six mosquito collection methods in western Kenya. Malar J 12: 143.
23. O'Meara WP, Collins WE, McKenzie FE (2007) Parasite prevalence: A static measure of dynamic infections. Am J Trop Med Hyg 77(2): 246-249.
24. Hay SI, Snow RW (2006) The Malaria Atlas Project: Developing global maps of malaria risk. PLoS Med 3(12): E473.
25. Gething PW, et al. (2011) A new world malaria map: Plasmodium falciparum endemicity in 2010. Malar J 10(1): 378.
26. Trape JF, Rogier C (1996) Combating malaria morbidity and mortality by reducing transmission. Parasitol Today 12(6): 236-240.
27. Ghani AC, et al. (2009) Loss of population levels of immunity to malaria as a result of exposure-reducing interventions: Consequences for interpretation of disease trends. PLoS One 4(2): E4383.
28. Cibulskis RE, Aregawi M, Williams R, Otten M, Dye C (2011) Worldwide incidence of malaria in 2009: Estimates, time trends, and a critique of methods. PLoS Med 8(12): E1001142.
29. Bekessy A, Molineaux L, Storey J (1976) Estimation of incidence and recovery rates of Plasmodium falciparum parasitaemia from longitudinal data. Bull World Health Organ 54(6): 685-693.
30. Singer B, Cohen JE (1980) Estimating malaria incidence and recovery rates from panel surveys. Math Biosci 49(3-4): 273-305.
31. Beier JC, et al. (1994) Plasmodium falciparum incidence relative to entomologic inoculation rates at a site proposed for testing malaria vaccines in western Kenya. Am J Trop Med Hyg 50(5): 529-536.
32. Rogier C, et al. (1999) Plasmodium falciparum clinical malaria: Lessons from longitudinal studies in Senegal. Parassitologia 41(1-3): 255-259.
33. Owusu-Agyei S, et al. (2001) Incidence of symptomatic and asymptomatic Plasmodium falciparum infection following curative therapy in adult residents of northern Ghana. Am J Trop Med Hyg 65(3): 197-203.
34. Baird JK, et al. (2002) Seasonal malaria attack rates in infants and young children in northern Ghana. Am J Trop Med Hyg 66(3): 280-286.
35. Mueller I, et al. (2012) Force of infection is key to understanding the epidemiology of Plasmodium falciparum malaria in Papua New Guinean children. Proc Natl Acad Sci USA 109(25): 10030-10035.
36. Drakeley C, Cook J (2009) Chapter 5. Potential contribution of sero-epidemiological analysis for monitoring malaria control and elimination: Historical and current perspectives. Adv Parasitol 69: 299-352.
37. Cook J, et al. (2010) Using serological measures to monitor changes in malaria transmission in Vanuatu. Malar J 9(1): 169.
38. Elliott SR, et al. (2014) Research priorities for the development and implementation of serological tools for malaria surveillance. F1000Prime Rep 6: 100-113.
39. Corran P, Coleman P, Riley E, Drakeley C (2007) Serology: A robust indicator of malaria transmission intensity? Trends Parasitol 23(12): 575-582.
40. Corran PH, et al. (2008) Dried blood spots as a source of anti-malarial antibodies for epidemiological studies. Malar J 7: 195.
41. Stewart L, et al. (2009) Rapid assessment of malaria transmission using age-specific sero-conversion rates. PLoS One 4(6): E6083.
42. Bruce-Chwatt LJ, Dodge JS, Draper CC, Topley E, Voller A (1972) Sero-epidemiological studies on population groups previously exposed to malaria. Lancet 1(7749): 512-515.
43. Bruce-Chwatt LJ, Draper CC, Avramidis D, Kazandzoglou O (1975) Sero-epidemiological surveillance of disappearing malaria in Greece. J Trop Med Hyg 78(9): 194-200.
44. Esposito F, et al. (1988) Prevalence and levels of antibodies to the circumsporozoite protein of Plasmodium falciparum in an endemic area and their relationship to resistance against malaria infection. Trans R Soc Trop Med Hyg 82(6): 827-832.
45. Ramasamy R, Nagendran K, Ramasamy MS (1994) Antibodies to epitopes on merozoite and sporozoite surface antigens as serologic markers of malaria transmission: Studies at a site in the dry zone of Sri Lanka. Am J Trop Med Hyg 50(5): 537-547.
46. Grab B, Pull JH; WHO (1974) Statistical Considerations in Serological Surveys of Population with Particular Reference to Malaria. Available at apps.who.int//iris/handle/10665/65700. Accessed December 13, 2014.
47. Drakeley CJ, et al. (2005) Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci USA 102(14): 5108-5113.
48. Cook J, et al. (2011) Serological markers suggest heterogeneity of effectiveness of malaria control interventions on Bioko Island, equatorial Guinea. PLoS One 6(9): E25137.
49. Badu K, et al. (2012) Marked variation in MSP-119 antibody responses to malaria in western Kenyan highlands. BMC Infect Dis 12: 50.
50. Bretscher MT, et al. (2013) Measurement of Plasmodium falciparum transmission intensity using serological cohort data from Indonesian schoolchildren. Malar J 12: 21.
51. Supargiyono S, et al. (2013) Seasonal changes in the antibody responses against Plasmodium falciparum merozoite surface antigens in areas of differing malaria endemicity in Indonesia. Malar J 12: 444.
52. Arnold BF, et al. (2014) Serological measures of malaria transmission in Haiti: Comparison of longitudinal and cross-sectional methods. PLoS One 9(4): E93684.
53. von Fricken ME, et al. (2014) Age-specific malaria seroprevalence rates: A crosssectional analysis of malaria transmission in the Ouest and Sud-Est departments of Haiti. Malar J 13: 361.
54. Meraldi V, et al. (2004) Natural antibody response to Plasmodium falciparum Exp-1, MSP-3 and GLURP long synthetic peptides and association with protection. Parasite Immunol 26(6-7): 265-272.
55. Gray JC, et al. (2007) Profiling the antibody immune response against blood stage malaria vaccine candidates. Clin Chem 53(7): 1244-1253.
56. Osier FHA, et al. (2008) Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect Immun 76(5): 2240-2248.
57. Akpogheneta OJ, et al. (2008) Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific. Infect Immun 76(4): 1748-1755.
58. Stanisic DI, et al. (2015) Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response. Infect Immun 83(2): 646-660.
59. Kilama M, et al. (2014) Estimating the annual entomological inoculation rate for Plasmodium falciparum transmitted by Anopheles gambiae s.l. using three sampling methods in three sites in Uganda. Malar J 13: 111.
60. Kinyanjui SM, Bull P, Newbold CI, Marsh K (2003) Kinetics of antibody responses to Plasmodium falciparum-infected erythrocyte variant surface antigens. J Infect Dis 187(4): 667-674.
61. Boutlis CS, et al. (2003) Immunoglobulin G (IgG) responses to Plasmodium falciparum glycosylphosphatidylinositols are short-lived and predominantly of the IgG3 subclass. J Infect Dis 187(5): 862-865.
62. Bousema JT, Drakeley CJ, Sauerwein RW (2006) Sexual-stage antibody responses to P. falciparum in endemic populations. Curr Mol Med 6(2): 223-229.
63. Kinyanjui SM, Conway DJ, Lanar DE, Marsh K (2007) IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life. Malar J 6: 82.
64. Doolan DL, Dobaño C, Baird JK (2009) Acquired immunity to malaria. Clin Microbiol Rev 22(1): 13-36.
65. Moncunill G, et al. (2013) High antibody responses against Plasmodium falciparum in immigrants after extended periods of interrupted exposure to malaria. PLoS One 8(8): E73624.
66. Ondigo BN, et al. (2014) Estimation of recent and long-term malaria transmission in a population by antibody testing to multiple Plasmodium falciparum antigens. J Infect Dis 210(7): 1123-1132.
67. Bousema T, et al. (2010) Serologic markers for detecting malaria in areas of low endemicity, Somalia, 2008. Emerg Infect Dis 16(3): 392-399.
68. Wong J, et al. (2014) Serological markers for monitoring historical changes in malaria transmission intensity in a highly endemic region of Western Kenya, 1994-2009. Malar J 13(1): 451.
69. Bejon P, et al. (2010) Stable and unstable malaria hotspots in longitudinal cohort studies in Kenya. PLoS Med 7(7): E1000304.
70. Crompton PD, et al. (2010) A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc Natl Acad Sci USA 107(15): 6958-6963.
71. Voller A, O'Neill P (1971) Immunofluorescence method suitable for large-scale application to malaria. Bull World Health Organ 45(4): 524-529.
72. Druilhe P, et al. (1986) Levels of antibodies to Plasmodium falciparum sporozoite surface antigens reflect malaria transmission rates and are persistent in the absence of reinfection. Infect Immun 53(2): 393-397.
73. Vekemans J, Ballou WR (2008) Plasmodium falciparum malaria vaccines in development. Expert Rev Vaccines 7(2): 223-240.
74. Felgner PL, et al. (2013) Pre-erythrocytic antibody profiles induced by controlled human malaria infections in healthy volunteers under chloroquine prophylaxis. Sci Rep 3: 3549.
75. Baum E, et al. (2013) Protein microarray analysis of antibody responses to Plasmodium falciparum in western Kenyan highland sites with differing transmission levels. PLoS One 8(12): E82246.
76. Noland GS, et al. (2008) Low prevalence of antibodies to preerythrocytic but not blood-stage Plasmodium falciparum antigens in an area of unstable malaria transmission compared to prevalence in an area of stable malaria transmission. Infect Immun 76(12): 5721-5728.
77. Bailey JA, et al. (2015) Seroreactivity to a large panel of field-derived Plasmodium falciparum apical membrane antigen 1 and merozoite surface protein 1 variants reflects seasonal and lifetime acquired responses to malaria. Am J Trop Med Hyg 92(1): 9-12.
78. Travassos MA, et al. (2013) Seroreactivity to Plasmodium falciparum erythrocyte membrane protein 1 intracellular domain in malaria-exposed children and adults. J Infect Dis 208(9): 1514-1519.
79. Ondigo BN, et al. (2012) Standardization and validation of a cytometric bead assay to assess antibodies to multiple Plasmodium falciparum recombinant antigens. Malar J 11: 427.
80. Simonsen J, et al. (2008) Sero-epidemiology as a tool to study the incidence of Salmonella infections in humans. Epidemiol Infect 136(7): 895-902.
81. Simonsen J, et al. (2009) Estimation of incidences of infectious diseases based on antibody measurements. Stat Med 28(14): 1882-1895.
82. de Melker HE, Versteegh FGA, Schellekens JFP, Teunis PFM, Kretzschmar M (2006) The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. J Infect 53(2): 106-113.
83. Kretzschmar M, Teunis PFM, Pebody RG (2010) Incidence and reproduction numbers of pertussis: Estimates from serological and social contact data in five European countries. PLoS Med 7(6): E1000291.
84. Sturrock HJW, et al. (2013) Targeting asymptomatic malaria infections: Active surveillance in control and elimination. PLoS Med 10(6): E1001467.
85. Cotter C, et al. (2013) The changing epidemiology of malaria elimination: New strategies for new challenges. Lancet 382(9895): 900-911.
86. WHO (2014) WHO procedures for certification of malaria elimination. Wkly Epidemiol Rec 89(29): 321-325.
87. Greenhouse B, et al. (2011) Antibodies to Plasmodium falciparum antigens predict a higher risk of malaria but protection from symptoms once parasitemic. J Infect Dis 204(1): 19-26.
88. Bejon P, et al. (2009) Analysis of immunity to febrile malaria in children that distinguishes immunity from lack of exposure. Infect Immun 77(5): 1917-1923.
89. Bejon P, et al. (2011) Effect of the pre-erythrocytic candidate malaria vaccine RTS,S/AS01E on blood stage immunity in young children. J Infect Dis 204(1): 9-18.
90. Bousema T, Kreuels B, Gosling R (2011) Adjusting for heterogeneity of malaria transmission in longitudinal studies. J Infect Dis 204(1): 1-3.
91. Jagannathan P, et al. (2014) IFN?/IL-10 co-producing cells dominate the CD4 response to malaria in highly exposed children. PLoS Pathog 10(1): E1003864.
92. Wanzira H, et al. (2014) Longitudinal outcomes in a cohort of Ugandan children randomized to artemether-lumefantrine versus dihydroartemisinin-piperaquine for the treatment of malaria. Clin Infect Dis 59(4): 509-516.
93. Kamya MR, et al. (2015) Malaria transmission, infection, and disease at three sites with varied transmission intensity in Uganda: Implications for malaria control. Am J Trop Med Hyg 92(5): 903-912.
94. Okello PE, et al. (2006) Variation in malaria transmission intensity in seven sites throughout Uganda. Am J Trop Med Hyg 75(2): 219-225.
95. Doolan DL, et al. (2008) Profiling humoral immune responses to P. falciparum infection with protein microarrays. Proteomics 8(22): 4680-4694.
96. Trieu A, et al. (2011) Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens. Mol Cell Proteomics 10(9): 007948.
97. Richards JS, et al. (2013) Identification and prioritization of merozoite antigens as targets of protective human immunity to plasmodium falciparum malaria for vaccine and biomarker development. J Immunol 191(2): 795-809.
98. Osier FH, et al. (2014) Opsonic phagocytosis of Plasmodium falciparum merozoites: Mechanism in human immunity and a correlate of protection against malaria. BMC Med 12: 108.
99. R Core Team (2014) R: A Language and Environment for Statistical Computing. Available at www.R-project.org. Accessed November 1, 2014.
100. Wang J, et al. (2014) robust: Robust Library. Available at cran.r-project.org/web/packages/robust/index.html. Accessed November 1, 2014.
101. Sboner A, et al. (2009) Robust-linear-model normalization to reduce technical variability in functional protein microarrays. J Proteome Res 8(12): 5451-5464.
102. Polley E, van der Laan M (2013) SuperLearner: Super Learner Prediction. Available at cran.r-project.org/web/packages/SuperLearner/index.html. Accessed November 1, 2014.
103. van der Laan MJ, Polley EC, Hubbard AE (2007) Super learner. Stat Appl Genet Mol Biol 6(2007): Article25.
104. Van der Laan M, Polley E, Hubbard A (2007) Super Learner. UC Berkeley Division of Biostatistics Working Paper Series. Available at biostats.bepress.com/ucbbiostat/paper222. Accessed November 1, 2014.
105. Friedman J, Hastie T, Tibshirani R (2010) Regularization paths for generalized linear models via coordinate descent. J Stat Softw 33(1): 1-22.
106. Liaw A, Wiener M (2002) Classification and regression by randomForest. R News Newsl R Proj 2(3): 18-22.
107. Meyer D, Dimitriadou E, Hornik K, Weingessel A, Leisch F (2014) e1071: Misc Functions of the Department of Statistics (e1071), TU Wien. Available at cran.r-project. org/web/packages/e1071/index.html. Accessed November 1, 2014.
108. Venables WN, Ripley BD (2002) Modern Applied Statistics with S. Available at www.stats.ox.ac.uk/pub/MASS4. Accessed November 1, 2014.
109. Sing T, Sander O, Beerenwinkel N, Lengauer T (2005) ROCR: Visualizing classifier performance in R. Bioinformatics 21(20): 3940-3941.